Study at a glance
What does a usual vitamin D blood test tell you?
It measures total 25-hydroxyvitamin D, the main circulating form used to assess vitamin D status. It provides useful information, but it does not directly measure vitamin D activity in every organ.
Why can vitamin D results change between tests?
Season, recent vitamin D exposure, body size, illness and changes in carrier proteins can affect the result. Different laboratory methods can also contribute to an apparent change.
Does a small change around a cut-off always mean a major change in health?
No. Normal variation and measurement differences can move a result across a cut-off even when the underlying change is small. Interpretation depends on what was measured, the method, the timing, the person’s condition and the clinical question.
Read the full article below ↓A vitamin D blood test can be useful without being self-explanatory. The result reflects a particular metabolite, a particular analytical method, a particular moment in time and a particular physiological state. Context matters because the same numerical concentration can arise under different combinations of season, recent exposure, body size, binding proteins, illness and laboratory method.
A result answers a narrower question than it appears to
Most routine vitamin D testing measures total 25-hydroxyvitamin D [25(OH)D]. That is the preferred general marker of vitamin D status because it reflects vitamin D input over a much longer time scale than the tightly regulated active hormone. But it still measures what is circulating in serum or plasma. It does not directly measure tissue uptake, local activation, receptor signalling or biological effect.
This distinction becomes important when a reader sees a single number and assumes it represents every layer of vitamin D physiology. A result can be accurate for its intended measurand while remaining incomplete for a broader question.
The laboratory method is part of the context
Automated immunoassays and LC-MS/MS do not have identical strengths and weaknesses. Automated methods are practical and high-throughput but can differ in D2 recovery, matrix sensitivity and cross-reactivity. LC-MS/MS can separate vitamin D forms more specifically but still depends on chromatography, calibration and validation. Therefore a change between laboratories or methods can add an analytical component to an apparent biological change.
This is one reason Variability in Vitamin D Measurements is not merely a technical laboratory topic. Method variability can alter how confidently serial results are compared.
Time of year changes the background physiology
For many people, UVB exposure varies strongly across the year. Circulating 25(OH)D therefore tends to rise after higher-exposure months and fall after lower-exposure months. A winter value can legitimately be lower than a summer value in the same person without implying that a new disease process has appeared between the two tests.
A single measurement can still be clinically useful. The limitation is treating it as a permanent year-round average. When interpretation depends on long-term status, season and previous measurements can materially change the picture.
Illness can alter the blood compartment itself
Acute inflammatory states can change fluid balance, albumin, vitamin D-binding protein and vascular distribution. In some longitudinal studies, 25(OH)D falls rapidly after a major inflammatory insult. In others, including acute malaria, it does not. That heterogeneity is exactly why context is needed: illness should prompt caution, not a predetermined correction.
If a result is obtained during major surgery, critical illness or another substantial physiological disturbance, it may not be directly comparable with a stable outpatient measurement. The test is still reporting the specimen accurately; the question is whether the specimen represents the person’s usual state.
Binding proteins can change the interpretation of total concentration
Because most 25(OH)D is carried by vitamin D-binding protein, changes in that protein can affect total concentrations and the relationship between total and free vitamin D. Pregnancy raises vitamin D-binding protein. Liver disease can reduce vitamin D-binding protein and albumin. Protein-losing conditions can alter the circulating carrier pool in other ways.
These situations do not invalidate total 25(OH)D as the standard general marker. They show why unusual carrier physiology can make a total concentration less straightforward than it is in a stable healthy adult.
Body size changes distribution
People with obesity commonly have lower circulating 25(OH)D and a smaller rise after equivalent vitamin D exposure. The evidence supports distribution-volume effects as an important explanation. In a larger body compartment, the same amount of vitamin D does not necessarily produce the same serum concentration as it would in a smaller distribution volume.
This matters for interpretation because a serum concentration is a concentration, not a direct inventory of total vitamin D in every compartment. It also helps explain why dose response can differ between people.
Biological noise becomes most visible near cut-offs
Small real or analytical changes matter most when a result lies close to a decision threshold. A person can move from one label to another because of season, assay bias or ordinary within-person variation even though biology does not change discontinuously at the threshold itself. Biological Noise in Vitamin D Testing explains why serial movement should be interpreted in relation to expected variation rather than by the raw difference alone.
Marker choice is a separate contextual decision
Sometimes the problem is not interpretation of 25(OH)D but selection of the wrong metabolite for the clinical question. The active hormone 1,25-dihydroxyvitamin D is tightly regulated and can be normal or high when 25(OH)D is low. Conversely, specialised disorders of calcium or phosphate physiology can require measurements beyond routine total 25(OH)D. Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D explains that distinction.
A better way to read the number
A useful vitamin D interpretation asks four questions together: what metabolite was measured; how it was measured; when and under what physiological conditions the sample was taken; and what clinical question the result is being used to answer. This framework preserves the value of testing without pretending the number is more comprehensive than it is.
The strongest conclusion from the evidence is therefore contextual rather than sceptical. Vitamin D blood tests are informative tools, but their meaning is conditional. A result becomes more useful, not less, when the reader understands the analytical and physiological circumstances that produced it.
Primary evidence and publication details
Dirks NF, Cavalier E, Heijboer AC. Vitamin D: marker, measurand & measurement. Endocrine Connections. 2023;12(4):e220269. PMID: 36688810. PMCID: PMC10083657. DOI: 10.1530/EC-22-0269. Read the full study.
Reid D, Toole BJ, Knox S, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. American Journal of Clinical Nutrition. 2011;93(5):1006-1011. PMID: 21411617. DOI: 10.3945/ajcn.110.008490. Read the full study.
Shoben AB, Kestenbaum B, Levin G, et al. Seasonal Variation in 25-Hydroxyvitamin D Concentrations in the Cardiovascular Health Study. American Journal of Epidemiology. 2011;174(12):1363-1372. PMID: 22112344. PMCID: PMC3276302. DOI: 10.1093/aje/kwr258. Read the full study.
Related reading
25-Hydroxyvitamin D and Vitamin D Binding Protein Levels in Patients With Primary Hyperparathyroidism Before and After Parathyroidectomy
To evaluate vitamin D binding protein and free 25-hydroxyvitamin D [25(OH)D] levels in healthy controls compared to primary hyperparathyroidism (PHPT) patients, and to examine PHPT before and after surgery.
Original paper ↗Read more →Association of Blood Levels of Vitamin D and Its Binding Protein with Clinical Phenotypes of Multiple Sclerosis
Background: Low vitamin D levels may synergize with changing levels of the vitamin D binding protein (DBP) to precipitate in the development and clinical progression of multiple sclerosis (MS).
Original paper ↗Read more →Association of vitamin D-binding protein and vitamin D3 with insulin and homeostatic model assessment (HOMA-IR) in overweight and obese females
This study was conducted to evaluate the relationships among 25(OH)D, VDBP, glucose/insulin metabolism and homeostatic model assessment (HOMA-IR).
Original paper ↗Read more →Changes in circulating 25-hydroxyvitamin D according to vitamin D binding protein genotypes after vitamin D3 or D2 supplementation
We aimed to investigate the changes of total 25(OH)D, 25(OH)D3 and 25(OH)D2 in a Thai cohort, according to type of vitamin D supplement (vitamin D3 or D2) and DBP genotype, after receiving vitamin D3 or D2 for 3 months.
Original paper ↗Read more →Deconvoluting the Biological Roles of Vitamin D-Binding Protein During Pregnancy: A Both Clinical and Theoretical Challenge
The teleological purpose of an ongoing pregnancy is to fulfill its fundamental role of a successful, uncomplicated delivery, in conjunction with an optimal intrauterine environment for the developing fetus.
Original paper ↗Read more →Diurnal rhythms of vitamin D binding protein and total and free vitamin D metabolites
The free 1,25(OH)2D DR was attenuated compared to that of total 1,25(OH)2D.
Original paper ↗Read more →Genetic associations with 25-hydroxyvitamin D deficiency in HIV-1-infected youth: fine-mapping for the GC/DBP gene that encodes the vitamin D-binding protein
Serum 25-hydroxyvitamin D [25(OH)D] is often deficient (.
Original paper ↗Read more →Genetic variant in vitamin D-binding protein is associated with metabolic syndrome and lower 25-hydroxyvitamin D levels in polycystic ovary syndrome: A cross-sectional study
All participants were genotyped for polymorphisms rs2282679, rs4588, and rs7041.
Original paper ↗Read more →Maternal and Neonatal Vitamin D Binding Protein Polymorphisms and 25-Hydroxyvitamin D Cutoffs as Determinants of Neonatal Birth Anthropometry
Our aim was to assess the combined effect of maternal and neonatal VDBP polymorphism heterogeneity in conjunction with different maternal and neonatal 25(OH)D cutoffs on the neonatal anthropometric profile at birth.
Original paper ↗Read more →Prevalence of vitamin D deficiency in women from southern Brazil and association with vitamin D-binding protein levels and GC-DBP gene polymorphisms
The aim of this study was to assess the prevalence of 25-hydroxyvitamin D [25(OH)D] deficiency and to ascertain whether it is associated with DBP levels and with GC gene variants.
Original paper ↗Read more →Search for Disease-Specific Genetic Markers Originated from the Vitamin D Binding Protein Gene Polymorphisms in the Multiple Sclerosis Cohort in the Latvian Population
This study examines the association of GC polymorphisms (rs7041, rs4588) with MS susceptibility and their impact on 25-hydroxyvitamin D [25(OH)D] levels in a Latvian cohort.
Original paper ↗Read more →The GC2 haplotype of the vitamin D binding protein is a risk factor for a low plasma 25-hydroxyvitamin D concentration in a Han Chinese population
Compared with VDI, VDS, or both, VDD showed higher plasma concentrations of fasting blood glucose, high-density lipoprotein cholesterol, low-density lipoprotein cholesterol, and triglycerides in males (P 0.05).
Original paper ↗Read more →The Role of Vitamin D Binding Protein, Total and Free 25-Hydroxyvitamin D in Diabetes
Vitamin D is important for bone health, but may also have extra-skeletal effects.
Original paper ↗Read more →Upregulation of Placental Vitamin D Receptor Expression in Gestational Diabetes Is Not Directly Related to Vitamin D Concentration
This study aimed to examine the expression of the vitamin D receptor in the placenta of patients with gestational diabetes mellitus and healthy women.
Original paper ↗Read more →Urinary Vitamin D Binding Protein and KIM-1 Are Potent New Biomarkers of Major Adverse Renal Events in Patients Undergoing Coronary Angiography
The purpose of our study was to explore the potential role of urinary VDBP as a biomarker of an acute renal damage.
Original paper ↗Read more →Vitamin D-Binding Protein, Bioavailable, and Free 25(OH)D, and Mortality: A Systematic Review and Meta-Analysis
Introduction: Observational studies reported inverse associations between serum total 25-hydroxyvitamin D (25(OH)D) concentrations and mortality.
Original paper ↗Read more →Vitamin D Binding Protein Genotype Is Associated with Serum 25-Hydroxyvitamin D and PTH Concentrations, as Well as Bone Health in Children and Adolescents in Finland
We examined the role of GC genotypes in S-25(OH)D status and BMD in 231 Finnish children and adolescents aged 7−19 yr.
Original paper ↗Read more →Vitamin D Binding Protein Impact on 25-Hydroxyvitamin D Levels under Different Physiologic and Pathologic Conditions
The aim of this review is to assess DBP concentration in different physiological and pathophysiological conditions.
Original paper ↗Read more →Vitamin D-Binding Protein Polymorphisms, 25-Hydroxyvitamin D, Sunshine and Multiple Sclerosis
Blacks have different dominant polymorphisms in the vitamin D-binding protein (DBP) gene that result in higher bioavailable vitamin D than whites.
Original paper ↗Read more →Vitamin D, Vitamin D Binding Protein, and Longitudinal Outcomes in COPD
We aimed to further investigate these associations on longitudinal outcomes.
Original paper ↗Read more →Vitamin D Binding Protein Explained
A physiology-first explanation of vitamin D binding protein, detailing how it buffers circulation, regulates delivery, and shapes cellular and system-level vitamin D availability.
Read more →Original sources
Read the full study
Dirks NF, Cavalier E, Heijboer AC.
Publication details
Dirks NF, Cavalier E, Heijboer AC. Vitamin D: marker, measurand & measurement. Endocrine Connections. 2023;12(4):e220269. PMID: 36688810. PMCID: PMC10083657. DOI: 10.1530/EC-22-0269. Read the full study.
Read the full study
Reid D, Toole BJ, Knox S, et al.
Publication details
Reid D, Toole BJ, Knox S, et al. The relation between acute changes in the systemic inflammatory response and plasma 25-hydroxyvitamin D concentrations after elective knee arthroplasty. American Journal of Clinical Nutrition. 2011;93(5):1006-1011. PMID: 21411617. DOI: 10.3945/ajcn.110.008490. Read the full study.
Read the full study
Shoben AB, Kestenbaum B, Levin G, et al.
Publication details
Shoben AB, Kestenbaum B, Levin G, et al. Seasonal Variation in 25-Hydroxyvitamin D Concentrations in the Cardiovascular Health Study. American Journal of Epidemiology. 2011;174(12):1363-1372. PMID: 22112344. PMCID: PMC3276302. DOI: 10.1093/aje/kwr258. Read the full study.